StonvexLoading…
StonvexStonvexStonvexCore line items from LMAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $249.60M | $219.86M | $193.48M | $161.65M |
Operating Income | $67.91M | $52.26M | $36.71M | $26.83M |
Net Income | $57.73M | $44.04M | $30.11M | $20.64M |
EPS (Diluted) | $2.52 | $1.93 | $1.34 | $0.93 |
Total Assets | $615.69M | $551.82M | $346.78M | $310.48M |
Total Liabilities | $222.17M | $214.53M | $48.88M | $42.27M |
Cash & Equivalents | $28.24M | $25.61M | $24.27M | $19.13M |
Free Cash Flow OCF − CapEx | $74.47M | $37.16M | $29.49M | $22.15M |
Shares Outstanding | 22.77M | 22.55M | 22.42M | 22.17M |